References
- Upton GV. The physiology of the perimenopausal years: a minireview. Int J Gynecol Obstet 1980;17: 531–45
- Boulet MJ, Oddens BJ, Lehert P, et al. Climacteric and menopause in seven south-east Asian coun-tries. Maturitas 1994;19:157–76
- Lindsay R. Prevention of postmenopausal osteo-porosis. Obstet Gynecol Clin N Am 1987;14:63–76
- Kleerekoper M, Brienza RS, Schultz LR, et al. Oral contraceptive use may protect against low bone mass. Arch Intern Med 1991;151:1971–6
- Stampfer MJ, Willett WC, Colditz GA, et al. A prospective study of postmenopausal estrogen therapy and coronary heart disease. N Eng J Med 1985;313:1044–9
- Stampfer MJ, Colditz GA, Willett WC, et al. Postmenopausal estrogen therapy and cardiovascu-lar disease. Ten-year follow up from the nurses' health study. N Eng J Med 1991;325:756–62
- Tzingounis VA, Aksu MF, Greenblatt RB. Estriol in the management of the menopause. J Am Med Assoc 1978;239:1638–41
- Yang TS, Tsan SH, Chang SP, et al. Efficacy and safety of estriol replacement therapy for climacteric women. Chung Hua I Hsueh Tsa Chih (Taipei) (TAIWAN) 1995;55:386–91
- Henriksson L, Stjernquist M, Boquist L, et al. A comparative multicenter study of the effects of con-tinuous low-dose estradiol released from a new vaginal ring versus estriol vaginal pessaries in post-menopausal women with symptoms and signs of urogenital atrophy. Am J Obstet Gynecol 1994;171: 624–32
- Di Stefano L, Patacchiola F, Moscarini M. Trans-vaginal administration of estriol in postmenopausal urogynecological disorders. Clin Obstet Gynecol 1993;45:551–6
- Cardozo L, Rekers H, Tapp A, et al. Oestriol in the treatment of postmenopausal urgency: a multi-centre study. Maturitas 1993;18:47–53
- Raz R, Stamm WE. A controlled trial of intra-vaginal estriol in postmenopausal women with recurrent urinary tract infections. N Eng J Med 1993;329:753–6
- Head KA. Estriol: safety and efficacy. Altern Med Rev 1998;3:101–3
- Ushiroyama T, Yoshikawa M, Sugimoto 0. Hypergonadotropinemia with estradiol secretion in peri- and postmenopausal period. Acta Obstet Gynecol Scand 1989;68:139–43
- Greene JG. Constructing a standard climacteric scale. Maturitas 1998;29:25–31
- Weinstein L. Efficacy of a continuous estrogen-progestin regimen in the menopausal patient. Obstet Gynecol 1987;69:929–32
- Melis GB, Cagnacci A, Bruni V, et al. Salmon calcitonin plus intravaginal estriol: an effective treatment for the menopause. Maturitas 1996;24: 83–90
- Clark JH, Paszko Z, Peck EJ Jr. Nuclear binding and retention of the receptor estrogen complex: relation to the agonistic and antagonistic properties of estriol? Endocrinology 1977;100: 91
- Minaguchi H, Uemura T, Shirasu K. Effect of estriol on bone loss in postmenopausal Japanese women: a multicenter prospective study. J Obstet Gynecol Res 1996;22:259–65
- Mattsson LA, Cullberg G, Samsioe G. Evaluation of continuous combined oestrogen/progestogen regimen for climacteric complaints. Maturitas 1982;4:95–102
- Weinstein L, Bewtra C, Gallagher J. Evaluation of continuous combined low-dose regimen ofoestro-gen-progestin for treatment of the menopausal patient. Am J Obstet Gynecol 1990;156:1534–9
- Hargrove J, Maxon W, Wentz J, et al. Menopausal hormone replacement therapy with continuous daily oral micronized estradiol and progesterone. Obstet Gynecol 1989;73:606–12